Impact of COVID-19-related regulatory changes on nationwide access to buprenorphine: An interrupted time series design is a dataset published in Drug and Alcohol Dependence Reports (2023). On theSindex it has a DataRank of 0.818, placing it in the top 24.6% of the data-sharing corpus. It has been cited 12 times, with 9 citing works in its 1-hop citation network.
Ranks in the top 25% for downstream scientific impact
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.385
From this paper's citation signal
Citation Network Contribution
0.434
From 4 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 9 citers.
NIDA CTN
Grant: 3UG1DA049436-03S1
National Institutes of Health
Grant: 3UG1DA049436-04S2
Appalachian Node
NIDA NIH HHS
Grant: UG1 DA049436
FWCI
2.82
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals